|
|
||||||||


* Department of Infectious Diseases, Imperial College of Science, Technology and Medicine (Hammersmith Campus), London, and
School of Biomedical Sciences and Institute of Cell Signalling, University Hospital, Nottingham, United Kingdom
Correspondence: Dr. Eleni Stylianou, School of Biomedical Sciences, University Hospital, Nottingham, United Kingdom. E-mail: eleni.stylianou{at}nottingham.ac.uk
Monocyte phagocytosis of pathogens or inflammatory debris leads to
chemokine secretion and heralds the influx of leukocytes to the site of
injury. Persistent chemokine secretion can lead to tissue damage.
However, the mechanisms by which phagocytosis regulates chemokine
synthesis remain poorly understood. As a first step, we have studied
regulation of interleukin (IL) 8 gene expression after interaction with
zymosan or latex. IL-8 secretion was consistently one- or twofold
higher after incubation with zymosan than with latex. Nuclear factor
(NF)
B translocation to the nucleus was induced by zymosan but not
latex, indicating that its translocation is dependent on the nature of
the phagocytic stimulus. NF
B activation coincided with I
B
degradation but had no effect on processing of NF
B1/p105, the
precursor of the NF
B protein p50. The NF
B inhibitor gliotoxin
abrogated zymosan-induced IL-8 synthesis in peripheral blood monocytes,
further demonstrating that the induction of IL-8 mRNA by zymosan is
NF
B dependent. SB203580 inhibition of the p38 mitogen-activated
protein kinase (MAPK) pathway significantly decreased zymosan-induced
IL-8 mRNA accumulation. Inhibitors of protein kinases A and C or
tyrosine kinases had no significant effect on zymosan-induced IL-8
synthesis. These data indicate that p38 MAPK and NF
B are critical in
controlling zymosan-induced IL-8 secretion.
Key Words: chemokine synthesis MAPK tyrosine kinase protein kinase NF-
B activation
This article has been cited by other articles:
![]() |
K. A. Gauss, L. K. Nelson-Overton, D. W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn Role of NF-{kappa}B in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-{alpha} J. Leukoc. Biol., September 1, 2007; 82(3): 729 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Legrand-Poels, G. Kustermans, F. Bex, E. Kremmer, T. A. Kufer, and J. Piette Modulation of Nod2-dependent NF-{kappa}B signaling by the actin cytoskeleton J. Cell Sci., April 1, 2007; 120(7): 1299 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Wright and J. S. Friedland Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis J. Leukoc. Biol., June 1, 2004; 75(6): 1086 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Osakabe, A. Yasuda, M. Natsume, and T. Yoshikawa Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model Carcinogenesis, April 1, 2004; 25(4): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brickson, L. L. Ji, K. Schell, R. Olabisi, B. St. Pierre Schneider, and T. M. Best M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury J Appl Physiol, September 1, 2003; 95(3): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Culpitt, D. F. Rogers, P. Shah, C. De Matos, R. E. K. Russell, L. E. Donnelly, and P. J. Barnes Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 24 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hoffmann, O. Dittrich-Breiholz, H. Holtmann, and M. Kracht Multiple control of interleukin-8 gene expression J. Leukoc. Biol., November 1, 2002; 72(5): 847 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lopez-Franco, Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido, and C. Gomez-Guerrero Nuclear Factor-{kappa}B Inhibitors as Potential Novel Anti-Inflammatory Agents for the Treatment of Immune Glomerulonephritis Am. J. Pathol., October 1, 2002; 161(4): 1497 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. Xiao, K. Malcolm, G. S. Worthen, S. Gardai, W. P. Schiemann, V. A. Fadok, D. L. Bratton, and P. M. Henson Cross-talk between ERK and p38 MAPK Mediates Selective Suppression of Pro-inflammatory Cytokines by Transforming Growth Factor-beta J. Biol. Chem., April 19, 2002; 277(17): 14884 - 14893. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |